Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction.
Fiche publication
Date publication
janvier 2020
Journal
JACC. Heart failure
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Serenelli M, Jackson A, Dewan P, Jhund PS, Petrie MC, Rossignol P, Campo G, Pitt B, Zannad F, Ferreira JP, McMurray JJV
Lien Pubmed
Résumé
The purpose of this study was to investigate the effects of mineralocorticoid receptor antagonists (MRAs) on systolic blood pressure (SBP) and outcomes according to baseline SBP in patients with heart failure with reduced ejection fraction (HFrEF).
Mots clés
aldosterone, blood pressure, ejection fraction, eplerenone, heart failure, mineralocorticoid receptor, spironolactone
Référence
JACC Heart Fail. 2020 Jan 6;: